The final, formatted version of the article will be published soon.
MINI REVIEW article
Front. Endocrinol.
Sec. Adrenal Endocrinology
Volume 16 - 2025 |
doi: 10.3389/fendo.2025.1533711
This article is part of the Research Topic Enhancing Adrenal Tumor Diagnostics: Biomarkers and Molecular Mechanisms View all 8 articles
A rare manifestation of adrenocortical carcinoma as a mimic of pheochromocytoma: a case report and literature review
Provisionally accepted- 1 Department of Internal Medicine, Endocrinology and Diabetes, Medical University of Warsaw, Warsaw, Masovian, Poland
- 2 Department of Internal Medicine, Endocrinology and Diabetes, Mazovian Brodno Hospital, Warsaw Medical University, Warsaw, Masovian, Poland
The primary management in the care of patients with adrenal incidentalomas is to determine the oncologic risk, namely the possibility of malignancy. The first place among adrenal incidentaloma lesions requiring diagnosis and treatment promptly is adrenocortical carcinoma (ACC). Similarly, in the case of pheochromocytoma, the lack of early diagnosis worsens the patient's prognosis. Even though both ACC and pheochromocytoma are among the less frequent adrenal lesions, neither should be excluded during differential diagnostics, especially in patients with an equivocal clinical presentation and non-typical adenoma radiological features. ACC presenting as pheochromocytoma is one of the few cases described in the literature, some of them could not collect exhaustive clinical data. Herein, in this article, we would like to provide an overview of reported ACC cases clinically manifesting as pheochromocytoma, based on the clinical image of a 59-year-old female patient with unintentional weight loss, nonspecific abdominal pain, a diagnosis of hypertension and significantly elevated excretion of 3-methoxytyramine in a 24-hour urine collection, histopathologically diagnosed with ACC. The case presented emphasizes how crucial a comprehensive diagnostics and individual approach to the patient would be.
Keywords: Adrenocortical Carcinoma, Pheochromocytoma, Adrenal incidentaloma, Symptoms, Mild autonomous cortisol secretion
Received: 24 Nov 2024; Accepted: 20 Jan 2025.
Copyright: © 2025 Sobolewska, Respondek and Witek. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Joanna Sobolewska, Department of Internal Medicine, Endocrinology and Diabetes, Medical University of Warsaw, Warsaw, Masovian, Poland
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.